ESRX Related Analyst Ratings
-
Stifel Nicolaus Initiates Coverage on Express Scripts (ESRX) with a Hold
-
UBS Starts Numerous Healthcare Stocks: CAH, MCK, ESRX at Buy, PMC, OCR at Neutral
-
Barclays Maintains an 'Equalweight' on Express Scripts (ESRX), Raises PT
-
Leerink Swann Resumes Coverage on Medco Health Solutions (MHS) and Express Scripts (ESRX) with Outperform Ratings
-
Goldman Sachs Raises Price Targets for Healthcare Services; Upgrades ABC, Downgrades PSSI
-
Goldman Sachs Resumes Express Scripts (ESRX) at Buy, WLP at Neutral; Downgrades MHS
-
Barron's Article Makes Comments on CVS Caremark (CVS); Discounted Valuation May Vault Shares to $40 Level
-
SunTrust Upgrades Express Scripts (ESRX) to Buy
-
UBS Upgrades Express Scripts (ESRX) to Buy
-
ARGUS Upgrades Express Scripts (ESRX) to Buy
-
Goldman Sachs Lifts Price Target on Express Scripts (ESRX)
-
Goldman Sachs Upgrades Express Scripts (ESRX) to Buy
-
Maxim Initiates Coverage on Express Scripts (ESRX) with a Buy
-
Ameriprise Financial Names Express Scripts (ESRX) a Top Pick for 2009
-
Citi Upgrades Express Scripts (ESRX) to Buy
-
Thomas Weisel Upgrades Express Scripts (ESRX) to Overweight
-
Broadpoint Downgrades Express Scripts (ESRX) to Buy
-
UBS Downgrades Express Scripts (ESRX) to Neutral
-
ARGUS Reiterates 'Hold' Rating on Express Scripts (ESRX)
-
Citigroup downgrades Express Scripts (ESRX) and MedcoHealth (MHS) to Hold
-
J.P. Morgan Downgrades Express Scripts (ESRX) to Neutral
-
Deutsche Bank Starts Express Scripts (ESRX) at Buy
-
Merrill Lynch Downgrades Express Scripts (ESRX) to Neutral
-
Wachovia Downgrades Express Scripts (ESRX) to Market Perform
-
Morgan Stanley upgrades Express Scripts (ESRX) to Overweight
-
Matrix USA Research Upgrades Express Scripts Inc (ESRX) to Buy
-
Citigroup Analyst Comments on Express Scripts (ESRX), Raises Price Target to $110
-
CIBC Starts Express Scripts (ESRX) at Sector Outperformer
-
UBS upgrades Express Scripts (ESRX) to Buy
-
Credit Suisse reinstates coverage on Express Scripts (ESRX) with an Outperform
-
Merrill Lynch upgrades Express Scripts (ESRX) to Buy
-
Jefferies & Co Upgrades Express Scripts (ESRX) to Buy
-
Jefferies & Co Initiates Coverage on Express Scripts (ESRX) with a Hold
-
JP Morgan upgrades Express Scripts (ESRX) to Overweight
-
Jim Cramer Makes Positive Comments on Wendy's Int'l (WEN) and Express Scripts (ESRX)
-
Wachovia upgrades Express Scripts (ESRX) to Outperform
-
Goldman Sachs Upgrades Express Scripts Inc. (ESRX) to Neutral
-
UBS downgrades Express Scripts (ESRX) to Neutral
-
Prudential upgrades Express Scripts (ESRX) to Overweight
-
Morgan Stanley upgrades Express Scripts (ESRX) to Equal Weight
-
Susquehanna Upgrades Express Scripts (ESRX) to Positive
-
Citigroup Recommends Buying PBMs, Managed Care After Zocor below Generic price
-
Citigroup removes Bowater (BOW) and Express Scripts (ESRX) from the Recommended List
-
FTN Midwest Initiates Coverage on Express Scripts (ESRX) with a Buy
-
First Analyis Securities upgrades Express Scripts (ESRX) to Overweight
-
Citigroup Makes Changes to Industry Group Weighting, Recommended List
-
Morgan Stanley downgrades Express Scripts (ESRX) to Underweight (pre-open)
-
Citigroup Starts Express Scripts (ESRX) at Buy
-
Goldman Sachs Downgrades ESRX
-
Merrill Lynch Downgrades ESRX
Back to ESRX Stock Lookup
